These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 291948)

  • 41. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.
    Gresser I; Aguet M; Morel-Maroger L; Woodrow D; Puvion-Dutilleul F; Guillon JC; Maury C
    Am J Pathol; 1981 Mar; 102(3):396-402. PubMed ID: 6163363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes.
    Keay S; Grossberg SE
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4099-103. PubMed ID: 6159626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological activity of sera obtained by hyperimmunizing rabbits with interferon from mouse L cells.
    Kisielow B; Inglot AD; Chudzio T
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):37-44. PubMed ID: 444043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas.
    Greenberg AH; Miller V; Jablonski T; Pohajdak B
    J Immunol; 1984 Apr; 132(4):2129-34. PubMed ID: 6199424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):182-8. PubMed ID: 216746
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
    Sidky YA; Borden EC
    Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.
    Brodeur BR; Merigan TC
    J Immunol; 1975 Apr; 114(4):1323-8. PubMed ID: 163863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Increase in the sensitivity of leukemia cells, incubated in interferon, to the effect of immune serum].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Dec; 82(12):1459-61. PubMed ID: 1023976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dextran derivatives in single and combination chemotherapy against transplantable mouse ascites and solid tumors.
    Suzuki M; Mikami T; Kadowaki M; Matsumoto T; Suzuki S
    Cancer Res; 1977 Sep; 37(9):3448-54. PubMed ID: 69495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
    Lee SH; Kelley S; Chiu H; Stebbing N
    Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of leukaemia L1210 cells in culture: a comparison of clones differing in sensitivity to interferon.
    Wérenne J; Rousseau G
    Arch Int Physiol Biochim; 1976; 84(3):683-4. PubMed ID: 64234
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves.
    da Silva SL; Figueiredo PM; Yano T
    Eur J Pharmacol; 2007 Dec; 576(1-3):180-8. PubMed ID: 17716654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
    Sheeja K; Kuttan G
    Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.
    Lindahl P; Gresser I; Leary P; Tovey M
    Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1284-7. PubMed ID: 1063409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indomethacin and aspirin do not inhibit the antiviral or anti-proliferative actions of interferon.
    Tovey MG; Gresser I; Rochette-Egly C; Begon-Lours-Guymarho J; Bandu MT; Maury C
    J Gen Virol; 1982 Dec; 63(2):505-8. PubMed ID: 6185629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.